About PeptideStacks

PeptideStacks.co.uk is a UK research-literacy platform focused on a single, narrow question: what does the peer-reviewed literature actually show about peptide combinations — and how confident should a careful reader be in that evidence?

Editorial focus

We publish evidence reviews of peptide combinations. Individual per-peptide monographs are covered by our sister site PeptideAuthority.co.uk. Every stack review on this site contains:

• A conservative A–X evidence grade for the combination itself (not just its components)
• Mechanism of action of each individual peptide in the combination
• Summarised findings from in vitro, animal-model and (where available) human studies of the combination specifically
• Whether the combination has direct-combination evidence, or is inferred from monotherapy data
• Translational limitations — allometric scaling failures, species differences, publication bias
• UK regulatory context (MHRA classification, POM advertising, unlicensed-medicine implications)
• Study-context dose figures where reported in a paper, described as what the investigator dosed a research subject — not a protocol to follow
• Side-effect and contraindication signals from the literature
• FAQ block addressing common reader questions about how to interpret the evidence

Editorial process

Each new stack entry begins with a literature review on PubMed, Google Scholar and the European PMC. We require at least one published in vitro or animal-model study describing the combination (not just the individual peptides) before publishing a stack review. Where the combined evidence is weak or absent, we say so explicitly on the page and grade accordingly.

We do not publish anecdotal forum reports, dosing recommendations, cycle plans, self-administration guidance, sourcing advice, before/after content, or unsourced “industry-standard” dosing claims. Where a study-context dose figure appears in a review, it is attributed inline to the underlying paper.

What this site is not

PeptideStacks.co.uk is not a medical advice resource. It is not a protocol library, a dosing calculator, or a recommendation to self-administer any peptide compound. It is not a vendor (although we carry a clearly labelled sponsor block from our sister vendor PeptideBarn.co.uk on non-POM-adjacent pages, with the sponsor presence suppressed for UK POM-adjacent compounds — see our conflict-of-interest disclosure).

We provide a single perspective — the laboratory researcher’s — and only describe what the peer-reviewed record actually shows. See our full medical disclaimer & legal notice and our responsible-information policy.

Editors & reviewers

Pages carry an editorial byline pointing here. Each editor entry includes the credentials line rendered on every article, plus any registrar / ORCID URL used for JSON-LD attribution.

Sister sites

• PeptideAuthority.co.uk — comprehensive monographs for each individual peptide referenced here.
• PeptideBarn.co.uk — UK source of research-grade peptide products.

Contact

Questions, citation requests, or corrections? Reach us via the contact page.